Informa has announced the divestiture of the Life Sciences Media Brands Portfolio, previously part of UBM, to MJH Associates, a leading US-based, independent full-service healthcare education, market research and multi-channel medical communications company, for a consideration of just over $100m.
The divestiture forms part of Informa’s Progressive Portfolio Management (PPM) programme launched post the combination with UBM. This programme will increase the focus on businesses and brands with strong market positions in core verticals, where the enlarged Informa portfolio is committed to future growth and scale.
The transaction does not include the CBI events business, which has been combined with the branded Life Sciences business within the Knowledge & Networking Division of Informa. The businesses being acquired by MJH are a portfolio of Life Science Media Brands that were previously reported within 'Other Marketing Services' by UBM.
These brands generate revenue largely through a mix of advertising and sponsorship, and cover three core vertical markets: Healthcare, (including brands such as Medical Economics, Practical Cardiology, Dermatology Times), Pharma (LC/GC, Pharmaceutical Technology, Spectroscopy, BioPharm International), and Animal Health (DVM360, Vetted, Firstline).
Michael J. Hennessy, Jr., president of MJH Associates‚ commented: “The strategic purchase of UBM Life Sciences’ media assets leaves no question that MJH is dedicated to remaining at the forefront of delivering trusted health care information now and into the future. It furthers our overall commitment to providing diverse stakeholders — from providers to patients to caregivers — access to trusted and timely resources to help inform care and optimise outcomes."
